Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias

Journal of Hematology and Oncology

Volumn 2, Issue , 2009, Pages

  Yan, Ying ^a,b   Wieman, Eric A ^a,b   Guan, Xiuqin ^b   Jakubowski, Ann A ^c   Steinherz, Peter G ^c   O'Reilly, Richard J ^c  

^a St Luke's College   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; AGGRESSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RELAPSE; CANCER STAGING; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; DISEASE COURSE; DISSEMINATED CANCER; ENGRAFTMENT; FEMALE; HUMAN; IN VITRO STUDY; INOCULATION; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRESCHOOL CHILD; PROGNOSIS; REFRACTORY PERIOD; SCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; SUBCUTANEOUS NODULE; ACUTE DISEASE; ANIMAL; CANCER TRANSPLANTATION; EVALUATION; INFANT; LEUKEMIA; LYMPHOCYTE; MIDDLE AGED; MORTALITY; MOUSE MUTANT; PATHOLOGY; PREDICTION AND FORECASTING; XENOGRAFT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANIMALS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEUKEMIA; LYMPHOCYTES; MALE; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TRANSPLANTATION, HETEROLOGOUS; YOUNG ADULT;

EID: 74949142919     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-2-51     Document Type: Article

References (23)

1. Touw, Ruud Delwel, and Valeria Santini: Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. Bob Lowenberg Wim van Putten P Ivo, N Engl J Med 1993 328 614 619 10.1056/NEJM199303043280904 8429853
2. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. AE Hunter SY Rogers IA Roberts AJ Barrett N Russell, Blood 1993 82 3 899 903 8338952
3. Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway. KT Doepfner O Spertini A Arcaro, Leukemia 2007 21 9 1921 30 10.1038/sj.leu.2404813 17581609
4. Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15. T Kukita N Arima K Matsushita K Arimura H Ohtsubo Y Sakaki H Fujiwara A Ozaki T Matsumoto C Tei, Br J Haematol 2002 119 2 467 74 10.1046/j.1365-2141.2002.03813.x 12406087
5. Contribution of bone microenvironment to leukemogenesis and leukemia progression. F Ayala R Dewar M Kieran R Kalluri, Leukemia 2009 23 12 2233 2241
6. In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease. MC del Canizo A Brufau J Almeida J Galende MA Garcia Marcos A Mota R Garcia J Fernandez Calvo F Ramos P Fisac A Orfao JF San Miguel, Br J Haematol 1998 103 1 137 42 10.1046/j.1365-2141.1998.00962.x 9792300
7. Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes. RJ Harris AR Pettitt C Schmutz PD Sherrington M Zuzel JC Cawley SD Griffiths, J Immunol 2000 164 7 3887 93 10725751
8. Multidrug resistant cells with high proliferative capacity determine response to therapy in acute myeloid leukemia. PA te Boekhorst B Lowenberg J van Kapel K Nooter P Sonneveld, Leukemia 1995 9 6 1025 31 7541095
9. 7. A novel predictive model of outcome in de novo AML based on S-phase activity and proliferative response of blast cells to haemopoietic growth factors. MA Smith RW Luxton CJ Pallister JG Smith, Leuk Res 2002 26 4 345 8 10.1016/S0145-2126(01)00131-X 11839376
10. Detection and clinical significance of human acute myeloid leukaemia progenitors capable of long-term proliferation in vitro. H Sutherland A Blair S Vercauteren R Zapf, Br J Haematol 2001 114 296 306 10.1046/j.1365-2141.2001. 02927.x 11529847
11. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. T Lapidot C Sirard J Vormoor B Murdoch T Hoang J Cacerres-Cortes M Minden B Paterson M Callgiuri J Dick, Nature 1994 367 645 10.1038/367645a0 7509044
12. Humanized model to study leukemic stem cells. D Bonnet, Methods Mol Biol 2009 538 247 62 full-text 19277589
13. Childhood acute myeloid leukemia in mice with severe combined immunodeficiency. LM Chelstrom R Gunther J Simon SC Raimondi R Krance WM Crist FM Uckun, Blood 1994 84 20 8018918
14. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. DJ Pearce D Taussig K Zibara LL Smith CM Ridler C Preudhomme BD Young AZ Rohatiner TA Lister D Bonnet, Blood 2006 107 1166 1173 10.1182/blood-2005-06-2325 16234360
15. A robust xenotransplantation model for acute myeloid leukemia. PV Sanchez RL Perry JE Sarry AE Perl K Murphy CR Swider A Bagg JK Choi JA Biegel G Danet-Desnoyers M Carroll, Leukemia 2009 23 11 2109 17 10.1038/leu.2009.143 19626050
16. Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice. Y Yan O Salomon JP McGuirk D Dennig J Fernandez C Jagiello HN Nguyen N Collins P Steinherz RJ O'Reilly, Blood 1996 88 3137 314 8874214
17. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias. J McGuirk Y Yan B Childs J Fernandez L Barnett C Jagiello N Collins RJ O'Reilly, Bone Marrow Transplant 1998 22 4 367 74 10.1038/sj.bmt.1701343 9722072
18. Acute myeloid leukemia and acute promyelocytic leukemia. B Lowenberg JD Griffin MS Tallman, Hematology 2003 82 101 10.1182/asheducation-2003.1.82 14633778
19. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. C Kelaidi S Chevret S De Botton E Raffoux A Guerci X Thomas A Pigneux T Lamy F Rigal-Huguet S Meyer-Monard P Chevallier F Maloisel E Deconinck A Ferrant N Fegueux N Ifrah M Sanz H Dombret P Fenaux L Adès, J Clin Oncol 2009 27 16 2668 76 10.1200/JCO.2008.18.4119 19414681
20. Molecular target therapy - towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology. ZX Shen, J Hematol Oncol. 2009 2 Suppl 1 1
21. Acute promyelocytic leukemia: from highly fatal to highly curable. ZY Wang Z Chen, Blood 2008 111 5 2505 15 10.1182/blood-2007-07-102798 18299451
22. Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics. TK Gregory D Wald Y Chen JM Vermaat Y Xiong W Tse, J Hematol Oncol. 2009 2 23
23. Differentiation therapy of leukemia: 3 decades of development. D Nowak D Stewart HP Koeffler, Blood 2009 113 16 3655 65 10.1182/blood-2009-01-198911 19221035